ATG5 and breast cancer: For instance, ATG5 promotes the process leading to the fusion of MVBs with the plasma membrane in breast cancer cells; the inhibition of the ATG16L1 and ATG5-ATG12 complex markedly affects exosome biogenesis or their secretion, in addition to the sorting of LC3, a well-known autophagic marker, into exosomes [95].